Electronic Deprescribing Tool for the Prevention of PIP

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

280 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-02

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a cluster randomized control trial aimed to measure the effectiveness of an educational knowledge transfer intervention to prescribers on the discontinuation of two targeted classes: Benzodiazepines andNon-benzodiazepine hypnotics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Deprescribing: a Portrait and Out-comes of the Reduction of Polypharmacy in Portugal

NCT03283735

Polypharmacy Deprescriptions

UNKNOWN NA

Benzodiazepines Deprescribing in the Community Setting: Intervention Feasibility

NCT05929417

Benzodiazepine Deprescribing

UNKNOWN NA

Obstacles to Deprescribing Among French Patients Over 75 Years of Age Treated in the Geriatric Hospital Network

NCT05327634

Medication Abuse

COMPLETED

Evaluation of the Effectiveness of a Psychoeducational Intervention on Benzodiazepine Use in the Population Over 64 Years Old in Primary Care

NCT06950567

Benzodiazepines Deprescribing

ACTIVE_NOT_RECRUITING NA

Intervention to Improve Prescribing in Elderly Patients

NCT02712268

Elderly Internal Medicine Patients

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators intend to develop an electronic decision support tool based on the best evidence available. This electronic deprescribing tool provides the rationale on the indications of prescribing or deprescribing Benzodiazepines or/and Non-benzodiazepine hypnotics and also provides interactive tapering suggestion integrated on a calendar. It is designed to help family doctors with the goal of improving health outcomes for the elderly.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prevention Benzodiazepine Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Randomization

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electronic Deprescribing tool

GPs of enrolled patients with access to the electronic Deprescribing tool

Group Type EXPERIMENTAL

Electronic Deprescribing tool

Intervention Type OTHER

Each GP of the intervention group will have exclusive access to an electronic tool that will guide them on deprescribing. The innovative electronic tool created by the researchers provide the rationale on indications for prescribing or deprescribing Benzodiazepines or/and Non-benzodiazepine hypnotics and also provides an interactive tapering suggestion integrated on a calendar.

The tool emphasizes that any decision to continue or discontinue a drug remains a shared decision between GP and the patient.

The electronic Deprescribing tool is designed to support clinical decisions

Usual Care

Usual care By GP´s

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electronic Deprescribing tool

Each GP of the intervention group will have exclusive access to an electronic tool that will guide them on deprescribing. The innovative electronic tool created by the researchers provide the rationale on indications for prescribing or deprescribing Benzodiazepines or/and Non-benzodiazepine hypnotics and also provides an interactive tapering suggestion integrated on a calendar.

The tool emphasizes that any decision to continue or discontinue a drug remains a shared decision between GP and the patient.

The electronic Deprescribing tool is designed to support clinical decisions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients ≥65 years who have been taking Benzodiazepines or/and Non-benzodiazepine hypnotics for at least 3 months and who do not meet any exclusion criterion

Exclusion Criteria

* incapacity or unwillingness to provide written informed consent. Patient with dementia, psychotic disorder, a severe personality disorder; institutionalization; terminal illness, seizure disorders, rapid eye movement sleep disorders, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, epilepsy and periprocedural anesthesia

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No